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Randomized Comparison of Flow Reversal vs Distal Filter for Cerebral Protection
During Carotid Artery Stenting in Patients With Stable Carotid Disease
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Background: previous studies revealed high incidence (up to 80%) of new asymp-
tomatic cerebral lesion after CAS, with conﬂicting results comparing proximal pro-
tection with ﬁlter. Heterogeneity in patient selection, CAS techniques and operators’
experience could have biased previous results. We sought to establish if proximal
protection with ﬂow reversal, performed by experienced operators in a high volume
center, may be more effective than ﬁlters in preventing cerebral embolization during
CAS in patients with stable carotid disease.
Methods: patients undergoing CAS with cerebral embolic protection for internal carotid
artery stenosis were randomly assigned to ﬂow reversal (FR) or ﬁlter protection (FP).
The primary endpoint was the incidence of new cerebral ischemic lesions assessed by
diffusion-weighted magnetic resonance imaging (MRI). Secondary endpoints were: the
number and diameter of new ischemic lesions; the number of microembolic signals
(MES) assessed by bilateral transcranial Doppler monitoring during the all phases of the
procedure. Major cardiovascular and cerebral events (MACCE) at 30 days were
recorded. Expected rate of new cerebral lesion was 50% in FP, 17% in FR (as reported
in previous studies); with alfa 5% and 1-beta 80%, sample size was 60 patients.
Results: 60 consecutive patients (mean age 72+6.8)were randomized. Comparedwith FP
(n¼30), FR (n¼30) did not reduce the incidence, the number and the diameter of new
cerebral ischemic lesions (table). Lesions in the contralateral hemisphere were found in
3.3% and 0% of patients. Overall MES were not signiﬁcantly reduced by FR compared to
FP (table). The 30 day MACCE rate was 3.3% and 3.3% for FP versus FR (p NS).ﬁlter
(n¼30)
proximal
protection
(n¼30) p
patients with at least 1 new lesion 12 (16.6%) 3 (10%) 0.7
number of new lesions (mean + SEM) 0.4 + 0.26 0.16 + 0.1 0.41
diameter (mean + SEM) 4.83 + 0.5 6.6 + 1.6 0.18
MES (median (interquartile range)) 125 (91-161) 103 (87-185) 0.6Conclusions: in this randomized trial of patients with stable severe carotid disease
undergoing CAS, incidence of new ischemic lesions was very low in both groups. FR
protection did not signiﬁcantly reduce cerebral embolization.1164
PROCEDURES TOTAL
> 80 Y.
TOTAL
< 80 Y.
WITHOUT
EPD
WITH
EPD
WITHOUT
EPD
WITH
EPD
NBR 177 6 171 987 182 805
T.I.A. 3 (1,3%) 1 (17%) 2 (1,1%) 11 (1,1%) 3 (1,6%) 8 (1%)
MINOR STROKE 1 (0,6%) 1 (17%) 0 6 (0,6%) 3 (1,6%) 3 (0,4%)
MAJOR STROKE 0 0 0 3 (0,3%) 2 (1,1%) 1 (0,1%)
DEATH 0 0 0 5 (0,5%) 2 (1,1%) 3 (0,4%)
MI 0 0 0 1 (0.1%) 0 1 (0.1%)
DEATH /
STROKE / M.I.
1 (0,6%) 1 (17%) 0 15 (1,5%) 7 (3,8%) 8 (1,1%)
EPD: EMBOLIC PROTECTION DEVICESTCT-552
Particulates from Hydrophilic Coated Guiding Sheaths Embolize to the Brain
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Background: Peripheral vascular interventions frequently employ guiding sheathswith
surface modiﬁcations (ie, hydrophilic coatings) raising the concern for embolization.
Methods: A self-expanding stent and delivery system (SDS) were deployed in the
iliac and/or carotid arteries of 23 Yucatan miniswine. Access was via the femoral or
carotid arteries. SDS were deployed through a Cook Flexor Ansel Guiding Sheath
with a hydrophilic coating (AQ hydrophilic coating). In one non-stented control
animal the guiding sheath was advanced but no SDS was deployed. Animals were
euthanized at 3, 30, 90 & 180 days after intervention and brains were removed for
histological analysis. In addition, coating material from the surface of a non-deployed
guiding sheath was obtained and examined microscopically.
Results: The Cook guiding sheath was associated with intravascular accumulation of
an amorphous, non-refractile, non-crystalline, and non-birefringent embolic foreign
material in sections of porcine brain which, on H&E staining, appeared lightly
basophilic and slightly stippled. Material was observed at all time points and in all
major regions of the brain, involving 52% of all test animals, and in the non-stented
control animal. The incidence of embolic material was higher (63%) with carotid
access than femoral access (20%). Evidence of adverse effects related to embolized
material was limited to a single incidence of focally extensive chronic infarction in one
brain. In vitro incubation of the Cook guiding sheath was associated with progressive
separation and sloughing of its hydrophilic coating. Microscopic assessment of the
sloughed hydrophilic coating was interpreted to be morphologically consistent with
the emboli observed in the brains of animals exposed to the Cook guiding sheath.
Conclusions: The hydrophilic coating of Cook Flexor Ansel Guiding Sheaths
sloughed and embolized to the brain during deployment in a porcine model, especially
following carotid access. Further monitoring and documentation of potential side-
effects of embolized material in clinical scenarios is warranted.B162 JACC Vol 64/11/SuppTCT-553
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Evaluation of ﬂow reversal during carotid artery stenting as the ﬁrst choice for
embolic protection - no contraindications!
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Laura Vaskelyte5, Horst Sievert3
1CardioVascular Center Frankfurt, Frankfurt am Main, Germany, 2CardioVascular
Center Frankfurt, Minneapolis, United States, 3CardioVascular Center Frankfurt,
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Background: To assess the use of proximal protection devices in consecutive patients
as the preferred means of cerebral embolic protection for primary stenting of carotid
stenosis.
Methods: This was a prospective single-center study to evaluate the technical and
clinical success of proximal protection devices as the ﬁrst choice for embolic protection
in symptomatic (50%) and asymptomatic (70%) carotid stenosis. Proximal protec-
tion devices were used for embolic protection in 124 consecutive patients. No patients
had been excluded for anatomical reasons. The Gore Flow Reversal Device (W.L.Gore,
Flagstaff, AZ) was used in 92 patients, the Mo.Ma Ultra device in 32 (Medtronic,
Minneapolis, MN) patients. We have used the Mo.Ma Ultra so that we were able to
establish a ﬂow reversal with this system, too. Follow-up duration was 30 days.
Results: Mean age was 71  8 years. Seventy-ﬁve percent of patients were male
(n¼93). Twenty-six of 124 (21%) treated stenoses were symptomatic. Technical success
was achieved in 122 of 124 cases (98%). Due to the anatomical conditions, in 2 patients,
ﬂow reversal could not be established. In both cases, additional distal ﬁlter devices were
used. Carotid stenting was successful in 124 lesions (100%). Ten patients (8.1%) had
classic contraindications to ﬂow reversal (3 high-grade ostial stenoses of the external
carotid artery, 7 contralateral occlusions of the internal carotid artery) in none of whom
any complications occurred. There were no procedural neurological events. Within 30
days of follow-up, one patient had an ischemic stroke on day 11.
Conclusions: Proximal protection using ﬂow reversal is a safe method as the ﬁrst
choice of embolic protection. It can be used with a high rate of technical success.
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Background: Recent studies, registries (EXACT, CAPTURE.) randomized studies
(CREST) have shown that carotid angioplasty stenting (CAS) is at higher risk than
surgery (CEA) in elderly patients. The aim of this study was to evaluate if CAS
performed in octogenarians is as safe as surgery with better indications, choice of the
devices, experienced operators.
Methods: 1104 patients (male 794) mean age 70.8  9.7 years underwent 1164 CAS
for de novo lesions (n¼1022) restenoses (n¼57) post radiation (n¼15) inﬂammatory
arteritis (n¼12) post trauma aneurysms (n¼2). Indications for treatment: symptomatic
carotid stenosis > 70 % (63%) or asymptomatic stenosis > 80 %. Patients were
separated into 2 age groups: > 80 y (174 patients, 177 CAS) and < 80 y (930 patients,
987 CAS). 188 CAS performed without protection (N.P-) 6 in patients >80 y, 976
with protection (NP+) (occlusion balloon: 334, ﬁlters: 637, reversal ﬂow: 6) 171 in
patients >80y. Data analysis included neurological complications, death and
myocardial infarction (MI) rate at 30 days, anatomical particularities. Technical points
will be described depending on the age of the patient.
Results: -Technical success < 80 years: 985/987 >80 years: 176/177
-Technical success
< 80 years: 985/987
>80 years: 176/177
-30 day outcomesl B j September 13–17, 2014 j TCT Abstracts/Carotid Intervention
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMConclusions: CAS can be performed in elderly patients without higher risk than in
younger patients. But good indications, a meticulous technique, protection devices are
mandatory and some technical points must be pointed out to avoid neurological
complications and failures.
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Optical Coherence Tomography in Carotid Artery Stenting: Feasibility and Safety
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Background: Optical coherence tomography (OCT) is an optical signal acquisition
and processing method that captures micrometer-resolution, three-dimensional images
from within optical scattering media that has a higher homoaxial resolution than
intravascular ultrasound. Currently, characterization of carotid atherosclerotic disease
is based on the anatomic degree of stenosis; however, imaging technologies such as
OCT can be a useful adjunct to provide additional information in characterizing ca-
rotid atherosclerotic disease and guiding therapeutic interventions without increasing
perioperative morbidity or mortality.
Methods: We evaluated 60 consecutive patients (35 men; mean age 75  4 years)
undergoing protected carotid artery stenting (CAS) since OCT was available in our lab
(November 2011). 27 of these 60 patients underwent CAS utilizing OCT evaluation
and guidance; the remainder underwent CAS without OCT guidance. Our purpose is
twofold: (1) to present the ﬁrst published US experience (and largest experience
globally) utilizing OCT to guide CAS from a safety and feasibility standpoint and to
demonstrate that OCT does not increase procedure time or perioperative morbidity or
mortality; and to (2) highlight 3 substantive cases to explain challenges in image
acquisition, image interpretation, and using images to guide interventional strategy.
Results: Noprocedural or in-hospital neurological complications occurred in either group
(stroke/death 0%). The total amounts of contrast and ﬂuoroscopic time/dose did not vary
signiﬁcantly between those patients undergoing OCT-guided CAS or CAS without OCT
guidance. OCT images revealed innovative features such as rupture of the ﬁbrous cap,
plaque prolapse, large lipid pool, and stent malapposition in a high percentage of patients;
these ﬁndings were then used to guide intraoperative decision-making.
Conclusions: Intravascular OCT during CAS appears to be feasible and safe. We have
established a protocol to successfully, consistently and safely obtain images that may
subsequently be used to guide interventional decision-making with the ultimate aim of
improving short and long-term outcomes.
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Carotid Artery Stenting with Double Cerebral Embolic Protection in
Symptomatic Patients
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Background: Previous trials comparing carotid artery stenting (CAS) with carotid
endarterectomy (CEA) demonstrated controversial results, mainly in symptomatic pa-
tients, because of higher stroke rate. However, the increase of the experience of the
operators, the improvement of the stents and of the embolic protection devices (EPD) has
made CAS a highly competitive procedure. In this study we tried to assess the feasibility
and the safety of using double EPD (proximal and distal) in high-risk patients.
Methods: We collected data about all consecutive patients with symptomatic or
asymptomatic carotid artery stenosis who underwent CAS and analyzed clinical and
procedural characteristics as well as immediate and 30-day outcomes. All the pro-
cedures were performed after discussion of the cases and after reviewing imaging
examination results with neurologists. Neurologic visits and duplex scans were
scheduled 24 hours and 1 month after the procedure.
Results: Between November 2007 to March 2014 277 underwent CAS. In 26 of them
(9.4%) double EPD was used (distal ﬁlter + MoMa, Medtronic, Minneapolis, MN).
The whole population was at high cardiovascular risk: 51.9% of the patients had
known coronary artery disease, 5.8% congestive heart failure, 41.9 % aged 75 years.
Many patients (48.7%) had a complex plaque (soft, ulcerated, with thrombus). The
stent implanted were closed-cell in 64.6%, hybrid in 23.5% and open cell in 11.9%. In
comparison with the patients treated with single EPD, those with double EPD pre-
sented with a higher rate of complex plaque (100% vs 43.4%, p< 0.0001). There was
no difference between the 2 groups in primary success (100% vs 96.4%, p¼0.16) and
in the rate of major complications at 30 days: death (0% vs 0.7%, p¼0.45), major
stroke (0% vs 0.8%, p¼0.45), and minor stroke (0% vs 1.2%, p¼0.66).
Conclusions: In our experience, in symptomatic patients with high-risk lesions, the
use of double EPD (proximal and distal) is safe and effective in minimizing the risk of
cerebral embolization.
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The Link Between S100b And Audio-Verbal Memory Performance In Patients
After Carotid Revascularization
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Background: S-100b has shown to be a sensitive marker of clinical and subclinical ce-
rebral damage, such as stroke andmild traumatic brain injury. In this studywe try to reveal
the link between S100B and postoperative cognitive impairment in patients undergoing
carotid revascularization by using the audio-verbal learning test (AVLT). The AVLT has
shown to be a sensitivemeasure for cognitive changes following carotid revascularization.
Methods: Blood samples were taken in 31 patients undergoing carotid revasculari-
zation (15 carotid endarterectomy, 6 carotid stenting (CAS) with ﬁlter protection
device, and 10 CAS with ﬂow reversal) pre-operatively, peri-operatively, and 2, 6, and
24 hours postoperatively. The serum S100b was measured using S100 Cobas. All
patients were cognitively tested one month postoperatively.
Results: For S100b, repeated measures show signiﬁcant within subjects differences
(ANOVA F¼19,64, p< 0,001 (see Figure 1). Because the two hours postoperative
S100b resulted in the highest peak value, this measure was used to correlate to AVLT
measures. There was no relation between the sum of the ﬁve encoding trials (r¼-0,172,
p¼ns.), but the long-term recall showed a non-signiﬁcant trend (r¼-0,338, p¼0,078).
Higher S100b values are associated with lower long-term audio-verbal memory scores.Conclusions: In this study S100b follows the typical increase early postoperatively, as
shown in other studies. The magnitude of this increase seems marginally correlated to
memory performance one month postoperatively. S100b may therefore have a pre-
dictive value for longer lasting cognitive impairments.
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Background: The purpose of this study was to introduce a novel and safe technique
with high procedural success for carotid artery stenting (CAS).
Methods: FromApril 2004 toMay 2009, 161 patients underwent CAS using either a high
transradial arterial approach (TRA, deﬁned as 10 cm above styloid process) or a trans-
brachial arterial approach (TBA) with a 7F arterial sheath. Selective carotid angiography
was performed using a 6F Kimny guiding catheter and Teﬂon wire (260 cm in length) by
Catheter Looping And Retrograde Engagement Technique (CLARET) with the guiding
catheter seated on the right coronary cusp and its tip engaged into the common carotid
artery (CCA). Teﬂon wire was introduced into the CCA again after the diagnostic pro-
cedure, followed by replacement of the 6FKimny guiding catheter by a 7FKimny catheter
for CAS using one of the following techniques: (1) direct-engagement method, i.e., from
right innominate artery into the right CCA; (2) loopingmethod plus double-wire technique
(utilized two Teﬂonwires to provide an adequate support) for both the right and left CCA;
and (3) loopingmethod plus a PercuSurge balloon anchoring at the external carotid artery.
Results: This distinctive technique offered 100% diagnostic success and 99.4% CAS
success. Two patients (1.2%) experienced major ischemic stroke after CAS and two
(1.2%) died during hospitalization.
Conclusions: The results of the present study showed that high TRA/TBA using
CLARET for CAS in patients with severe carotid artery stenosis is safe and techni-
cally feasible with an extremely high success rate.rotid Intervention B163
